Provides Fast, Easy Way for Seven Bridges Users to Access and Analyze Data Generated in Europe, under the Protection of EU Data Protection Regulations CAMBRIDGE, Mass. – Seven Bridges, the biomedical data analysis company, today announced that the Seven Bridges Platform is now live on the Amazon Web Services (AWS) EU (Frankfurt) Region in Frankfurt, Germany, […]

Companies Complete High Quality Assembly of Nellore Cattle Genome in Conjunction with Universidade Estadual Paulista SAN DIEGO & NESS ZIONA, Israel— Illumina, Inc. (NASDAQ: ILMN), the global leader in next-generation sequencing technology, and NRGene, a globally recognized leader in genome assembly and analysis, today announced a collaboration to develop new molecular breeding tools for cattle. As a first step, the […]

Leading Provider of Cloud-based Genomics Technology Joins HCA’s Global Cancer Institute to Grow Reach in Precision Medicine for People Facing Cancer Across the US & UK Nashville, Tenn. and Cambridge, Mass. – Sarah Cannon, the Cancer Institute of Hospital Corporation of America (HCA), today announced that Genospace, LLC, a cloud-based software company focused on advancing personalized medicine, […]

Cambridge, UK: Syngene, a world-leading manufacturer of image analysis solutions, is delighted to announce its GeneSys software has been upgraded to include an icon of pre-set optimised “stain-free” protein gel imaging conditions. This simple to use software, available to download free of charge to existing users of specified Syngene imaging systems, will save set-up time […]

Technology Platform Will Help Monsanto Analyze, Store And Mine Its Industry-Leading Broad Genomic Data Sets To Enhance Breeding And R&D Opportunities ST. LOUIS & NESS ZIONA, Israel–(BUSINESS WIRE)–Monsanto Company (NYSE: MON) and NRGene announced today that the companies have reached a non-exclusive, multi-year global licensing agreement on NRGene’s genome-analysis technology to enhance Monsanto’s ability to […]

Crescendo implements Genedata Biologics as backbone workflow system Basel, Switzerland – Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announces that Crescendo Biologics will use Genedata Biologics™ as its workflow platform. The platform will be used for both Crescendo’s internal and its partnered Humabody®-based therapeutics programs, with […]

Data interpretation from Watson will help users translate genomic data  from  Illumina TruSight® Tumor 170; offering to be available early in 2017 SAN FRANCISCO – IBM Watson Health (NYSE:IBM) and Illumina, Inc. (NASDAQ:ILMN) today announced a groundbreaking partnership to  expand access to genome data interpretation by integrating Watson for Genomics into  Illumina’s BaseSpace Sequence Hub and tumor sequencing […]

Collaboration aims to leverage Illumina’s  world-class DNA sequencing technology and BaseSpace Sequence Hub with Philips’ innovative cloud-based genomics platform for the acquisition, analysis and interpretation of genomics data in cancer research Amsterdam, the Netherlands, and  San Diego, US – Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Illumina, Inc.(NASDAQ:ILMN), the global leader in DNA […]

Powerful multi-omics data management solution and highly curated ‘omics’ data sets complement QIAGEN’s industry-leading interpretation solutions Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the acquisition of OmicSoft Corporation, providing access to OmicSoft’s powerful multi-omics data management infrastructure solution as well as expertly curated ‘omics’ data sets that […]

NIH funds development of a Recombinant Proteomic Data Resource for protein researchers to better share unpublished positive and negative gene-to-protein research outcomes. Seattle, WA — Transform Research, LLC dba Bio Data Bridges, a life science software and knowledge management company, received a Phase I Small Business Innovation Research (SBIR) grant from the National Institute of General […]